Antonio Bossi

4.4k total citations · 2 hit papers
49 papers, 1.9k citations indexed

About

Antonio Bossi is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Antonio Bossi has authored 49 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Endocrinology, Diabetes and Metabolism, 10 papers in Cardiology and Cardiovascular Medicine and 8 papers in Surgery. Recurrent topics in Antonio Bossi's work include Diabetes Treatment and Management (16 papers), Diabetes Management and Research (9 papers) and Chronic Kidney Disease and Diabetes (7 papers). Antonio Bossi is often cited by papers focused on Diabetes Treatment and Management (16 papers), Diabetes Management and Research (9 papers) and Chronic Kidney Disease and Diabetes (7 papers). Antonio Bossi collaborates with scholars based in Italy, Spain and United States. Antonio Bossi's co-authors include Giuseppe Remuzzi, Roberto Trevisan, Ilian Iliev, Aneliya Parvanova, Flavio Gaspari, Alessandro Roberto Dodesini, Annalisa Perna, Bogdan Ene‐Iordache, Nadia Rubis and Giulia Gherardi and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Diabetes Care.

In The Last Decade

Antonio Bossi

45 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Preventing Microalbuminuria in Type 2 Diabetes

2004 680 citations Piero Ruggenenti, Anna Fassi et al. New England Journal of Medicine profile →
Association of Obesity With Survival Outcomes in Patients With Cancer

2021 302 citations Antonio Bossi et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Antonio Bossi Italy	17	731	665	647	307	265	49	1.9k
Con Tsalamandris Australia	32	979 1.3×	1.3k 1.9×	540 0.8×	346 1.1×	310 1.2×	42	3.1k
Richard E. Gilbert Australia	24	839 1.1×	758 1.1×	681 1.1×	579 1.9×	230 0.9×	44	2.2k
Andrea Zuckerman United States	18	832 1.1×	355 0.5×	622 1.0×	248 0.8×	194 0.7×	32	2.4k
H.-H. Parving Denmark	18	989 1.4×	735 1.1×	769 1.2×	231 0.8×	241 0.9×	30	2.1k
Mari-Anne Gall Denmark	17	797 1.1×	667 1.0×	725 1.1×	253 0.8×	169 0.6×	26	2.1k
Allan Kofoed‐Enevoldsen Denmark	20	962 1.3×	1.0k 1.5×	914 1.4×	280 0.9×	243 0.9×	49	2.6k
Jean‐Claude Aldigier France	23	386 0.5×	622 0.9×	625 1.0×	312 1.0×	215 0.8×	63	1.9k
Hans Henrik Parving Denmark	11	582 0.8×	1.2k 1.8×	743 1.1×	264 0.9×	149 0.6×	12	2.9k
Lucía Cea Soriano Spain	24	550 0.8×	555 0.8×	463 0.7×	221 0.7×	219 0.8×	88	2.2k
Nils Heyne Germany	23	365 0.5×	540 0.8×	252 0.4×	373 1.2×	231 0.9×	87	1.7k

Countries citing papers authored by Antonio Bossi

Since Specialization

Citations

This map shows the geographic impact of Antonio Bossi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonio Bossi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonio Bossi more than expected).

Fields of papers citing papers by Antonio Bossi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonio Bossi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonio Bossi. The network helps show where Antonio Bossi may publish in the future.

Co-authorship network of co-authors of Antonio Bossi

This figure shows the co-authorship network connecting the top 25 collaborators of Antonio Bossi. A scholar is included among the top collaborators of Antonio Bossi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonio Bossi. Antonio Bossi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vena, Walter, Marco Mirani, Vincenzo Altieri, et al.. (2025). Diabetic Ketoacidosis: Considerations and Residual Controversies in Management After the 2024 ADA, EASD, JBDS, AACE, and DST Joint Consensus. Endocrine Metabolic & Immune Disorders - Drug Targets. 25.

Fanti, Alessandro De, et al.. (2025). Early administration of romosozumab prevents rebound of bone resorption related to denosumab withdrawal in fractured post-menopausal women: a real-world prospective study. Journal of Endocrinological Investigation. 48(5). 1249–1256. 3 indexed citations

Vena, Walter, et al.. (2024). COVID-19 vaccines and blood glucose control: Friend or foe?. Human Vaccines & Immunotherapeutics. 20(1). 2363068–2363068. 1 indexed citations

Pedersini, Rebecca, Deborah Cosentini, Rosalba Torrisi, et al.. (2023). Denosumab improves trabecular bone score in relationship with decrease in fracture risk of women exposed to aromatase inhibitors. Journal of Endocrinological Investigation. 47(2). 433–442. 6 indexed citations

Natalicchio, Annalisa, et al.. (2022). Patient-Support Program in Diabetes Care During the Covid-19 Pandemic: An Italian Multicentric Experience. SHILAP Revista de lepidopterología. 5 indexed citations

Natalicchio, Annalisa, et al.. (2022). Patient-Support Program in Diabetes Care During the Covid-19 Pandemic: An Italian Multicentric Experience. Patient Preference and Adherence. Volume 16. 113–122. 1 indexed citations

Ruggenenti, Piero, Monica Cortinovis, Matias Trillini, et al.. (2022). Long-term kidney and systemic effects of calorie restriction in overweight or obese type 2 diabetic patients (C.Re.S.O. 2 randomized controlled trial). Diabetes Research and Clinical Practice. 185. 109804–109804. 17 indexed citations

Vena, Walter, Alessandro Pizzocaro, Elisabetta Lavezzi, et al.. (2022). Serum testosterone mirrors inflammation parameters in females hospitalized with COVID-19. Journal of Endocrinological Investigation. 46(5). 939–945. 2 indexed citations

Carrara, Fabiola, Piero Ruggenenti, Annalisa Perna, et al.. (2021). Glomerular resistances predict long-term GFR decline in type 2 diabetic patients without overt nephropathy: a longitudinal subgroup analysis of the DEMAND trial. Acta Diabetologica. 59(3). 309–317. 2 indexed citations

10.

Bossi, Antonio, Franco Forloni, & Paolo Luigi Colombelli. (2020). Lack of Efficacy of SGLT2-i in Severe Pneumonia Related to Novel Coronavirus (nCoV) Infection: No Little Help from Our Friends. Diabetes Therapy. 11(7). 1605–1606. 13 indexed citations

11.

Giorda, Carlo, Emanuela Orsi, Salvatore De Cosmo, et al.. (2020). Prescription of Sulphonylureas among Patients with Type 2 Diabetes Mellitus in Italy: Results from the Retrospective, Observational Multicentre Cross-Sectional SUSCIPE (Sulphonyl_UreaS_Correct_Internal_Prescription_Evaluation) Study. Diabetes Therapy. 11(9). 2105–2119. 6 indexed citations

12.

Simioni, Natalino, Cesare Berra, Massimo Boemi, et al.. (2018). Predictors of treatment response to liraglutide in type 2 diabetes in a real-world setting. Acta Diabetologica. 55(6). 557–568. 18 indexed citations

13.

Veronesi, Giovanni, et al.. (2015). Determinants of nurse satisfaction using insulin pen devices with safety needles: an exploratory factor analysis. PubMed. 1(1). 15–15. 9 indexed citations

14.

Lenarda, Andrea Di, Riccardo Candido, Giovanni Cioffi, & Antonio Bossi. (2014). Lo studio SAVOR-TIMI 53. Giornale italiano di cardiologia. 15(6). 335–9. 1 indexed citations

15.

Gaspari, Flavio, Piero Ruggenenti, Esteban Porrini, et al.. (2013). The GFR and GFR decline cannot be accurately estimated in type 2 diabetics. Kidney International. 84(1). 164–173. 104 indexed citations

16.

Ruggenenti, Piero, Esteban Porrini, Nicola Motterlini, et al.. (2012). Measurable Urinary Albumin Predicts Cardiovascular Risk among Normoalbuminuric Patients with Type 2 Diabetes. Journal of the American Society of Nephrology. 23(10). 1717–1724. 64 indexed citations

17.

Ruggenenti, Piero, Ilian Iliev, Marco Filipponi, et al.. (2010). Effect of Trandolapril on Regression of Retinopathy in Hypertensive Patients with Type 2 Diabetes: A Prespecified Analysis of the Benedict Trial. Journal of Ophthalmology. 2010. 1–9. 16 indexed citations

18.

Loriot, Yohann, Christophe Massard, Marine Gross‐Goupil, et al.. (2009). Combining carboplatin and etoposide in docetaxel-pretreated patients with castration-resistant prostate cancer: a prospective study evaluating also neuroendocrine features. Annals of Oncology. 20(4). 703–708. 69 indexed citations

19.

Bianchi, M.L., Antonio Bossi, Danuta Chlebna‐Sokół, et al.. (2005). An international registry of fragility fractures in the young. Bone. 1 indexed citations

20.

Ruggenenti, Piero, Anna Fassi, Aneliya Parvanova, et al.. (2004). Preventing Microalbuminuria in Type 2 Diabetes. New England Journal of Medicine. 351(19). 1941–1951. 680 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact